Corporate News 13-Sep-17
Gufic BioSciences declare Quarterly Result
On 14 September 2017
Gufic BioSciences will hold a meeting of the Board of Directors of the Company on 14 September 2017.
Previous News
Gufic Biosciences gains on DCGA nod for Thymosin Alpha-1
( Hot Pursuit - 06-Apr-22 11:14 )
Gufic BioSciences receives upgrade in credit ratings for bank facilities
( Corporate News - 24-Jun-22 19:44 )
Gufic BioSciences standalone net profit rises 86.58% in the December 2017 quarter
( Results - Announcements 13-Feb-18 17:48 )
Gufic BioSciences to declare Quarterly Result
( Corporate News - 27-May-24 14:14 )
Gufic BioSciences to convene board meeting
( Corporate News - 14-May-22 16:40 )
Gufic BioSciences to hold board meeting
( Corporate News - 05-Aug-21 15:11 )
Gufic BioSciences standalone net profit rises 28.10% in the December 2016 quarter
( Results - Announcements 16-Feb-17 17:06 )
Gufic BioSciences receives NCLT, Ahmedabad bench approval for scheme of amalgamaiton
( Corporate News - 04-Jan-21 12:25 )
Gufic Biosciences added after receiving nod form DCGI for Thymosin Alpha – 1
( Hot Pursuit - 06-Apr-22 11:11 )
Gufic Biosciences receives no objection for scheme of amalgamation from exchanges
( Corporate News - 16-Apr-20 17:51 )
Gufic BioSciences standalone net profit rises 154.34% in the September 2017 quarter
( Results - Announcements 15-Dec-17 17:00 )
Other Stories
RailTel wins order of Rs 23.96 cr
04-Jul-24 19:25
Unicycive enters into manufacturing and supply agreement with Shipla Medicare
04-Jul-24 18:55
Mahindra Lifespace Developers acquires 2.37 land for development in South Bengaluru
04-Jul-24 18:27
Mahindra Lifespace Developers to undertake redevelopment project in Borivali, Mumbai
04-Jul-24 18:25
Ahluwalia Contracts wins order of Rs 572 cr
04-Jul-24 18:13
Dilip Buildcon divest 51% stake in project SPV (Pathrapali Kathgora Highways)
04-Jul-24 18:06
NBCC (India) wins work order from National Institute of Technology
04-Jul-24 16:15
CAMS appoints director
04-Jul-24 16:13
Alembic Pharmaceuticals receives USFDA tentative approval for Ivosidenib Tablets
04-Jul-24 16:11
Board of Lloyds Metals & Energy approves allotment of convertible warrants aggregating Rs 2960 cr
04-Jul-24 16:07
Back
Top
